Jeff Bezos backs Profluent with $106M; AI startup uses machine learning to custom-design programmable proteins for drug development and agriculture, nearing $1B valuation.

Jeff Bezos Is Backing An AI Startup Aiming To Make Proteins Programmable

Profluent founder Ali Madanijin hanProfluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture. Ali Madani started thinking about how AI could be programmed for biology in 2020, years before the launch of ChatGPT. The machine learning scientist was working at Salesforce, which that year launched a moonshot project, called ProGen, to design novel proteins with generative AI. “The same architecture used for English, you can use for biological ...